Breaking News Instant updates and real-time market news.

ADVM

Adverum Biotechnologies

$20.46 /

-0.58 (-2.76%)

16:09
05/28/20
05/28
16:09
05/28/20
16:09

Adverum Biotechnologies reports Q1 EPS (31c), consensus (27c)

Cash, cash equivalents and short-term investments were $297.1M as of March 31, compared to $166M as of December 31, 2019. In February, Adverum raised approximately $140.9M in net proceeds from an underwritten public offering. Adverum expects this quarter-end cash position to fund operations into 2022. "I'm thankful for the strong commitment and resilience our employees have exhibited towards advancing our pipeline despite the challenges of COVID 19," said Leone Patterson, president and CEO, Adverum Biotechnologies. "We continue to execute on our goal to develop and commercialize our novel gene therapy candidate ADVM-022 as a potential one-time treatment for patients with wet age-related macular degeneration (AMD) and DME, the two largest indications for anti-VEGF treatment. With the recent approval of our Investigational New Drug application for ADVM-022, we have initiated INFINITY in DME, a high-need subgroup of patients within the larger DR population. Additionally, we look forward to presenting data from all four cohorts of the OPTIC Phase 1 trial for ADVM-022 in wet AMD by the end of this year."

  • 28

    May

  • 23

    Jun

ADVM Adverum Biotechnologies
$20.46 /

-0.58 (-2.76%)

05/12/20 RBC Capital
Adverum Biotechnologies initiated with an Outperform at RBC Capital
05/05/20 Truist
Adverum Biotechnologies upgraded to Buy from Hold at SunTrust
05/05/20 Truist
Adverum Biotechnologies upgraded to Buy from Hold at SunTrust
04/28/20 Goldman Sachs
Adverum Biotechnologies initiated with a Buy at Goldman Sachs

TODAY'S FREE FLY STORIES

Syndicate
Phio Pharmaceuticals announces $14M private placement priced at-the-market » 15:35
01/21/21
01/21
15:35
01/21/21
15:35
PHIO

Phio Pharmaceuticals

$3.07 /

+ (+0.00%)

Phio Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PHIO Phio Pharmaceuticals
$3.07 /

+ (+0.00%)

08/05/20
Fly Intel: Top five analyst initiations
08/05/20 H.C. Wainwright
Phio Pharmaceuticals initiated with a Buy at H.C. Wainwright
Periodicals
Judge sides with Amazon in Parler web-hosting case, NPR says » 15:34
01/21/21
01/21
15:34
01/21/21
15:34
AMZN

Amazon.com

$3,316.24 /

+49.1 (+1.50%)

U.S. District Judge…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMZN Amazon.com
$3,316.24 /

+49.1 (+1.50%)

AMZN Amazon.com
$3,316.24 /

+49.1 (+1.50%)

08:39 Today BofA
Amazon.com price target raised to $4,000 from $3,650 at BofA
01/19/21 JPMorgan
JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration'
01/11/21 Baird
Baird remains a buyer of Amazon ahead of Q4 results
12/22/20 Wells Fargo
Microsoft's own semis 'a competitive headwind' for Intel, says Wells Fargo
AMZN Amazon.com
$3,316.24 /

+49.1 (+1.50%)

AMZN Amazon.com
$3,316.24 /

+49.1 (+1.50%)

AMZN Amazon.com
$3,316.24 /

+49.1 (+1.50%)

AMZN Amazon.com
$3,316.24 /

+49.1 (+1.50%)

Options
Seagate options imply 7.9% move in share price post-earnings » 15:34
01/21/21
01/21
15:34
01/21/21
15:34
STX

Seagate

$62.26 /

+0.83 (+1.35%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
STX Seagate
$62.26 /

+0.83 (+1.35%)

STX Seagate
$62.26 /

+0.83 (+1.35%)

07:08 Today Barclays
Seagate price target raised to $60 from $41 at Barclays
01/20/21 Wedbush
Seagate price target raised to $56 from $47 at Wedbush
01/19/21 Northland
Seagate price target raised to $72 from $65 at Northland
01/19/21 Loop Capital
Seagate price target raised to $70 from $60 at Loop Capital
STX Seagate
$62.26 /

+0.83 (+1.35%)

STX Seagate
$62.26 /

+0.83 (+1.35%)

STX Seagate
$62.26 /

+0.83 (+1.35%)

Options
Ambarella call volume above normal and directionally bullish » 15:25
01/21/21
01/21
15:25
01/21/21
15:25
AMBA

Ambarella

$110.03 /

+4.97 (+4.73%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMBA Ambarella
$110.03 /

+4.97 (+4.73%)

AMBA Ambarella
$110.03 /

+4.97 (+4.73%)

07:47 Today Stifel
Ambarella price target raised to $118 from $110 at Stifel
01/13/21 Roth Capital
Ambarella upgraded to Buy with $130 price target at Roth Capital
01/13/21 Roth Capital
Ambarella upgraded to Buy from Neutral at Roth Capital
01/05/21 Craig-Hallum
Ambarella price target raised to $115 from $90 at Craig-Hallum
AMBA Ambarella
$110.03 /

+4.97 (+4.73%)

AMBA Ambarella
$110.03 /

+4.97 (+4.73%)

AMBA Ambarella
$110.03 /

+4.97 (+4.73%)

Conference/Events
Jefferies auto/auto parts analyst to hold an analyst/industry conference call » 15:25
01/21/21
01/21
15:25
01/21/21
15:25

Auto & Auto Parts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Periodicals
Pfizer slashes vaccine deliveries to some EU countries by 50%, Reuters reports » 15:21
01/21/21
01/21
15:21
01/21/21
15:21
PFE

Pfizer

$36.45 /

-0.035 (-0.10%)

, BNTX

BioNTech

$107.01 /

+3.71 (+3.59%)

Pfizer (PFE) has cut in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PFE Pfizer
$36.45 /

-0.035 (-0.10%)

BNTX BioNTech
$107.01 /

+3.71 (+3.59%)

PFE Pfizer
$36.45 /

-0.035 (-0.10%)

01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
01/14/21 Oppenheimer
Essa Pharma price target raised to $20 from $9 at Oppenheimer
01/05/21 Argus
Viatris initiated with a Hold at Argus
12/31/20 Ladenburg
UK study supports potential of Arcturus COVID vaccine candidate, says Ladenburg
BNTX BioNTech
$107.01 /

+3.71 (+3.59%)

01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
12/29/20 Citi
Arcturus selloff brings 'very good' buying opportunity, says Citi
12/22/20 Roth Capital
Translate Bio price target raised to $37 from $30 at Roth Capital
12/15/20 Jefferies
Jefferies starts Maravai at Buy, says 'more than just a COVID vaccine play'
PFE Pfizer
$36.45 /

-0.035 (-0.10%)

BNTX BioNTech
$107.01 /

+3.71 (+3.59%)

  • 23
    Jul
  • 06
    Feb
PFE Pfizer
$36.45 /

-0.035 (-0.10%)

BNTX BioNTech
$107.01 /

+3.71 (+3.59%)

PFE Pfizer
$36.45 /

-0.035 (-0.10%)

BNTX BioNTech
$107.01 /

+3.71 (+3.59%)

PFE Pfizer
$36.45 /

-0.035 (-0.10%)

BNTX BioNTech
$107.01 /

+3.71 (+3.59%)

Periodicals
Biden poised to freeze oil, coal leasing on federal land, Bloomberg says » 15:20
01/21/21
01/21
15:20
01/21/21
15:20
ACI

Albertsons

$17.43 /

+0.12 (+0.69%)

, ANR

Alpha Natural

$0.00 /

+ (+0.00%)

, ARLP

Alliance Resource Partners

$5.26 /

-0.25 (-4.54%)

, CNX

CNX Resources

$12.32 /

-0.13 (-1.04%)

, BTU

Peabody Energy

$3.48 /

-0.495 (-12.47%)

, CLDP

Cloud Peak Energy

$0.00 /

+ (+0.00%)

President Joe Biden is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACI Albertsons
$17.43 /

+0.12 (+0.69%)

ANR Alpha Natural
$0.00 /

+ (+0.00%)

ARLP Alliance Resource Partners
$5.26 /

-0.25 (-4.54%)

CNX CNX Resources
$12.32 /

-0.13 (-1.04%)

BTU Peabody Energy
$3.48 /

-0.495 (-12.47%)

ACI Albertsons
$17.43 /

+0.12 (+0.69%)

01/20/21 Morgan Stanley
Albertsons downgraded to Underweight with $13 price target at Morgan Stanley
01/20/21 Morgan Stanley
Kroger downgraded to Underweight at Morgan Stanley
01/20/21 Morgan Stanley
Albertsons downgraded to Underweight from Equal Weight at Morgan Stanley
01/15/21 Tigress Financial
Tigress continues to recommend Albertsons purchases, sees further upside
ANR Alpha Natural
$0.00 /

+ (+0.00%)

ARLP Alliance Resource Partners
$5.26 /

-0.25 (-4.54%)

02/04/20 Benchmark
Benchmark starts 'under-owned and shunned' Alliance Resource Partners at Buy
02/04/20 Benchmark
Alliance Resource Partners initiated with a Buy at Benchmark
CNX CNX Resources
$12.32 /

-0.13 (-1.04%)

01/15/21 JPMorgan
CNX Resources initiated with an Overweight at JPMorgan
12/15/20 BofA
CNX Resources initiated with a Neutral at BofA
12/15/20 BofA
CNX Resources initiated with a Neutral at BofA
10/30/20 MKM Partners
CNX Resources upgraded to Buy from Neutral at MKM Partners
BTU Peabody Energy
$3.48 /

-0.495 (-12.47%)

08/07/20 Vertical Research
Peabody Energy downgraded to Hold from Buy at Vertical Research
05/07/20 Clarksons Platou
Peabody Energy downgraded to Neutral from Buy at Clarksons Platou
03/20/20 Deutsche Bank
Peabody Energy downgraded to Hold from Buy at Deutsche Bank
02/10/20 Benchmark
Benchmark starts Arch Coal at Buy, sees opportunity after selloff
CLDP Cloud Peak Energy
$0.00 /

+ (+0.00%)

ACI Albertsons
$17.43 /

+0.12 (+0.69%)

CNX CNX Resources
$12.32 /

-0.13 (-1.04%)

BTU Peabody Energy
$3.48 /

-0.495 (-12.47%)

  • 26
    Jun
ACI Albertsons
$17.43 /

+0.12 (+0.69%)

CNX CNX Resources
$12.32 /

-0.13 (-1.04%)

ACI Albertsons
$17.43 /

+0.12 (+0.69%)

CNX CNX Resources
$12.32 /

-0.13 (-1.04%)

ACI Albertsons
$17.43 /

+0.12 (+0.69%)

BTU Peabody Energy
$3.48 /

-0.495 (-12.47%)

Options
CSX options imply 4.6% move in share price post-earnings » 15:19
01/21/21
01/21
15:19
01/21/21
15:19
CSX

CSX

$91.77 /

-1.45 (-1.56%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CSX CSX
$91.77 /

-1.45 (-1.56%)

CSX CSX
$91.77 /

-1.45 (-1.56%)

01/20/21 Susquehanna
Railroad recovery expected to continue in 2021, says Susquehanna
01/11/21 Citi
CSX price target raised to $105 from $87 at Citi
12/10/20 Morgan Stanley
Morgan Stanley downgrades CSX to Underweight with bar raised too high
12/10/20 Morgan Stanley
CSX downgraded to Underweight from Equal Weight at Morgan Stanley
CSX CSX
$91.77 /

-1.45 (-1.56%)

CSX CSX
$91.77 /

-1.45 (-1.56%)

CSX CSX
$91.77 /

-1.45 (-1.56%)

Technical Analysis
NASDAQ market internals summary » 15:17
01/21/21
01/21
15:17
01/21/21
15:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
$0.00 /

+ (+0.00%)

Technical Analysis
NYSE market internals summary » 15:16
01/21/21
01/21
15:16
01/21/21
15:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
$0.00 /

+ (+0.00%)

Hot Stocks
Momentus announces service agreement with Qosmosys » 15:14
01/21/21
01/21
15:14
01/21/21
15:14
SRAC

Stable Road Acquisition

$23.70 /

-0.56 (-2.31%)

Momentus and Qosmosys…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SRAC Stable Road Acquisition
$23.70 /

-0.56 (-2.31%)

SRAC Stable Road Acquisition
$23.70 /

-0.56 (-2.31%)

SRAC Stable Road Acquisition
$23.70 /

-0.56 (-2.31%)

Recommendations
Unibail-Rodamco-Westfield price target lowered to EUR 45 at Barclays » 15:13
01/21/21
01/21
15:13
01/21/21
15:13
UNBLF

Unibail-Rodamco-Westfield

$0.00 /

+ (+0.00%)

Barclays analyst Sander…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UNBLF Unibail-Rodamco-Westfield
$0.00 /

+ (+0.00%)

12/10/20 Goldman Sachs
Unibail-Rodamco-Westfield upgraded to Buy from Neutral at Goldman Sachs
12/07/20 Deutsche Bank
Unibail-Rodamco-Westfield price target lowered to EUR 70 at Deutsche Bank
11/24/20 Goldman Sachs
Unibail-Rodamco-Westfield upgraded to Neutral from Sell at Goldman Sachs
11/23/20 JPMorgan
Unibail-Rodamco-Westfield resumed with an Underweight at JPMorgan
Recommendations
Svenska Handelsbanken price target raised to SEK 105 from SEK 102 at Barclays » 15:11
01/21/21
01/21
15:11
01/21/21
15:11
SVNLY

Svenska Handelsbanken

$0.00 /

+ (+0.00%)

Barclays analyst Namita…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SVNLY Svenska Handelsbanken
$0.00 /

+ (+0.00%)

01/14/21 SEB Equities
Svenska Handelsbanken upgraded to Hold from Sell at SEB Equities
01/11/21 UBS
Svenska Handelsbanken price target raised to SEK 89 from SEK 82 at UBS
12/09/20 Deutsche Bank
Svenska Handelsbanken price target raised to SEK 112 at Deutsche Bank
12/01/20 JPMorgan
Svenska Handelsbanken price target lowered to SEK 70 from SEK 75 at JPMorgan
Recommendations
Smith & Nephew price target lowered to 1,875 GBp from 1,900 GBp at Barclays » 15:10
01/21/21
01/21
15:10
01/21/21
15:10
SNN

Smith & Nephew

$44.83 /

-1.04 (-2.27%)

Barclays analyst Hassan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNN Smith & Nephew
$44.83 /

-1.04 (-2.27%)

SNN Smith & Nephew
$44.83 /

-1.04 (-2.27%)

13:47 Today Berenberg
Smith & Nephew price target raised to 2,005 GBp from 1,975 GBp at Berenberg
01/20/21 Berenberg
Smith & Nephew price target raised to 2,005 GBp from 1,975 GBp at Berenberg
12/18/20 JPMorgan
Smith & Nephew price target lowered to 1,438 GBp from 1,596 GBp at JPMorgan
12/18/20 Bernstein
Smith & Nephew upgraded to Outperform from Market Perform at Bernstein
Recommendations
Pearson price target raised to 630 GBp from 520 GBp at Barclays » 15:10
01/21/21
01/21
15:10
01/21/21
15:10
PSO

Pearson

$9.81 /

-0.23 (-2.29%)

Barclays analyst Nick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PSO Pearson
$9.81 /

-0.23 (-2.29%)

PSO Pearson
$9.81 /

-0.23 (-2.29%)

05:14 Today Exane BNP Paribas
Pearson downgraded to Neutral from Outperform at Exane BNP Paribas
01/12/21 Berenberg
Pearson price target raised to 475 GBp from 450 GBp at Berenberg
12/17/20 UBS
Pearson price target raised to 750 GBp from 650 GBp at UBS
12/09/20
Fly Intel: Top five analyst downgrades
PSO Pearson
$9.81 /

-0.23 (-2.29%)

Recommendations
Nordea Bank price target raised to SEK 7.60 from SEK 7.40 at Barclays » 15:09
01/21/21
01/21
15:09
01/21/21
15:09
NRDBY

Nordea Bank

$0.00 /

+ (+0.00%)

Barclays analyst Namita…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NRDBY Nordea Bank
$0.00 /

+ (+0.00%)

12/09/20 Deutsche Bank
Nordea Bank upgraded to Buy from Hold at Deutsche Bank
12/01/20 JPMorgan
Nordea Bank price target raised to SEK 75 from SEK 70 at JPMorgan
11/30/20 Barclays
Nordea Bank price target raised to EUR 7.40 from EUR 7.30 at Barclays
11/20/20 JPMorgan
Nordea Bank price target raised to SEK 70 from SEK 65 at JPMorgan
NRDBY Nordea Bank
$0.00 /

+ (+0.00%)

Hot Stocks
Old Point Financial announces Q4 pre-tax expenses of $1M » 15:06
01/21/21
01/21
15:06
01/21/21
15:06
OPOF

Old Point Financial

$20.75 /

+0.75 (+3.75%)

Old Point Financial plans…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
IMI PLC price target raised to 1,465 GBp from 1,230 GBp at Barclays » 15:06
01/21/21
01/21
15:06
01/21/21
15:06
IMIAY

IMI PLC

$0.00 /

+ (+0.00%)

Barclays analyst Jonathan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IMIAY IMI PLC
$0.00 /

+ (+0.00%)

01/18/21 Goldman Sachs
IMI PLC upgraded to Conviction Buy from Buy at Goldman Sachs
01/15/21 Morgan Stanley
IMI PLC price target raised to 1,400 GBp from 1,320 GBp at Morgan Stanley
01/13/21 Credit Suisse
IMI PLC upgraded to Outperform at Credit Suisse on guidance upside
01/13/21 Credit Suisse
IMI PLC upgraded to Outperform from Neutral at Credit Suisse
Periodicals
Parler loses request for injunction against Amazon, Bloomberg reports » 15:04
01/21/21
01/21
15:04
01/21/21
15:04
AMZN

Amazon.com

$3,319.68 /

+52.54 (+1.61%)

Previously it was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMZN Amazon.com
$3,319.68 /

+52.54 (+1.61%)

AMZN Amazon.com
$3,319.68 /

+52.54 (+1.61%)

08:39 Today BofA
Amazon.com price target raised to $4,000 from $3,650 at BofA
01/19/21 JPMorgan
JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration'
01/11/21 Baird
Baird remains a buyer of Amazon ahead of Q4 results
12/22/20 Wells Fargo
Microsoft's own semis 'a competitive headwind' for Intel, says Wells Fargo
AMZN Amazon.com
$3,319.68 /

+52.54 (+1.61%)

AMZN Amazon.com
$3,319.68 /

+52.54 (+1.61%)

AMZN Amazon.com
$3,319.68 /

+52.54 (+1.61%)

AMZN Amazon.com
$3,319.68 /

+52.54 (+1.61%)

Options
IBM options imply 6.3% move in share price post-earnings » 15:04
01/21/21
01/21
15:04
01/21/21
15:04
IBM

IBM

$132.01 /

+1.93 (+1.48%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IBM IBM
$132.01 /

+1.93 (+1.48%)

IBM IBM
$132.01 /

+1.93 (+1.48%)

10/20/20 Morgan Stanley
Morgan Stanley continues to view IBM as 'a 2022 stock'
10/20/20 Citi
IBM is 'getting even more complex,' says Citi
10/20/20 BMO Capital
IBM price target lowered to $138 from $140 at BMO Capital
10/09/20 Morgan Stanley
IBM price target raised to $140 from $128 at Morgan Stanley
IBM IBM
$132.01 /

+1.93 (+1.48%)

IBM IBM
$132.01 /

+1.93 (+1.48%)

IBM IBM
$132.01 /

+1.93 (+1.48%)

IBM IBM
$132.01 /

+1.93 (+1.48%)

Recommendations
DNB ASA price target raised to NOK 131 from NOK 120 at Barclays » 15:03
01/21/21
01/21
15:03
01/21/21
15:03
DNHBY

DNB ASA

$0.00 /

+ (+0.00%)

Barclays analyst Namita…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DNHBY DNB ASA
$0.00 /

+ (+0.00%)

01/11/21 Berenberg
DNB ASA price target raised to NOK 180 from NOK 150 at Berenberg
01/11/21 UBS
DNB ASA downgraded to Sell from Neutral at UBS
12/09/20 Deutsche Bank
DNB ASA price target raised to NOK 180 from NOK 151 at Deutsche Bank
12/01/20 JPMorgan
DNB ASA price target raised to NOK 180 from NOK 165 at JPMorgan
Recommendations
Danske Bank price target raised to DKK 105 from DKK 104 at Barclays » 15:02
01/21/21
01/21
15:02
01/21/21
15:02
DNKEY

Danske Bank

$0.00 /

+ (+0.00%)

Barclays analyst Namita…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DNKEY Danske Bank
$0.00 /

+ (+0.00%)

01/11/21 UBS
Danske Bank price target raised to DKK 138 from DKK 130 at UBS
12/09/20 Deutsche Bank
Danske Bank price target raised to DKK 115 from DKK 104 at Deutsche Bank
12/01/20 JPMorgan
Danske Bank price target lowered to DKK 95 from DKK 98 at JPMorgan
11/24/20 Morgan Stanley
Danske Bank downgraded to Underweight from Equal Weight at Morgan Stanley
Recommendations
BASF price target raised to EUR 64 from EUR 60 at Barclays » 15:01
01/21/21
01/21
15:01
01/21/21
15:01
BASFY

BASF

$0.00 /

+ (+0.00%)

Barclays analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BASFY BASF
$0.00 /

+ (+0.00%)

13:32 Today Deutsche Bank
BASF price target raised to EUR 86 from EUR 71 at Deutsche Bank
01/15/21 Berenberg
BASF price target raised to EUR 74 from EUR 52 at Berenberg
01/12/21 Bernstein
BASF upgraded to Outperform from Market Perform at Bernstein
01/11/21 JPMorgan
BASF downgraded to Underweight from Neutral at JPMorgan
BASFY BASF
$0.00 /

+ (+0.00%)

Periodicals
CoStar, Warburg group final bidders in running for CoreLogic, Bloomberg says » 15:01
01/21/21
01/21
15:01
01/21/21
15:01
CSGP

CoStar Group

$902.59 /

+1.59 (+0.18%)

, CLGX

CoreLogic

$77.33 /

+1.625 (+2.15%)

CoStar Group (CSGP) and a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CSGP CoStar Group
$902.59 /

+1.59 (+0.18%)

CLGX CoreLogic
$77.33 /

+1.625 (+2.15%)

CSGP CoStar Group
$902.59 /

+1.59 (+0.18%)

12/22/20 JMP Securities
RealPage price target raised to $101 from $80 at JMP Securities
11/23/20 Wells Fargo
CoStar Group price target raised to $990 from $915 at Wells Fargo
10/28/20 Truist
CoreLogic could be sold for 'meaningfully more' than $80 per share, says Truist
10/28/20 Needham
CoStar Group price target raised to $1,000 from $825 at Needham
CLGX CoreLogic
$77.33 /

+1.625 (+2.15%)

01/06/21 Wolfe Research
CoreLogic downgraded to Underperform from Peer Perform at Wolfe Research
12/01/20 Truist
CoreLogic downgraded to Hold from Buy at Truist
12/01/20 Truist
CoreLogic downgraded to Hold from Buy at Truist
10/28/20 Truist
CoreLogic could be sold for 'meaningfully more' than $80 per share, says Truist
CSGP CoStar Group
$902.59 /

+1.59 (+0.18%)

CLGX CoreLogic
$77.33 /

+1.625 (+2.15%)

  • 21
    May
CSGP CoStar Group
$902.59 /

+1.59 (+0.18%)

CLGX CoreLogic
$77.33 /

+1.625 (+2.15%)

CSGP CoStar Group
$902.59 /

+1.59 (+0.18%)

CLGX CoreLogic
$77.33 /

+1.625 (+2.15%)

Recommendations
Aveva price target raised to 3,730 GBp from 3,560 GBp at Barclays » 15:00
01/21/21
01/21
15:00
01/21/21
15:00
AVEVF

Aveva

$0.00 /

+ (+0.00%)

Barclays analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AVEVF Aveva
$0.00 /

+ (+0.00%)

AVEVF Aveva
$0.00 /

+ (+0.00%)

01/20/21 Berenberg
Aveva upgraded to Buy from Hold at Berenberg
01/05/21 UBS
Aveva upgraded to Buy from Neutral at UBS
01/04/21 Investec
Aveva upgraded to Buy from Hold at Investec
12/11/20 Credit Suisse
Aveva price target lowered to 3,620 GBp from 4,690 GBp at Credit Suisse

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.